Experience with the Hemasite vascular prosthesis.
A 3-year experience with the no-needle vascular prosthesis Hemasite, implanted in 10 patients who underwent hemodialysis and have a long history of multiple vascular access failures, is described. During 182 months of follow-up study, 30 thromboses occurred, while nine of 10 patients did not receive any antiplatelet aggregant treatment. Hemasite was declotted 12 times with a local infusion of urokinase and 12 more times by thrombectomy. A surgical procedure was performed only in the other cases, and the rate of surgical intervention fell from 0.18 interventions per patient per month before Hemasite implantation to 0.027 after implantation.
Viron
B
B
Services de Néphrologie A, Hopital Tenon, Paris.
Lukacs
B
B
Michel
C
C
Dosquet
P
P
Haddoum
F
F
Thibault
P
P
Mignon
F
F
D000328:Adult; D000368:Aged; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D006083:Graft Occlusion, Vascular / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D006435:Renal Dialysis; D013927:Thrombosis / Q000209:etiology*
D011138:Polytetrafluoroethylene